Oracle Argus Safety - More Clients Live With Latest Release

Friday, February 3, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

KAISERSLAUTERN, Germany, February 3, 2017 /PRNewswire/ --

pharmasol, a global leader in software development and

product implementation for the Life Sciences industry, today announced two new Argus hosted customers.

With an increased focus on E2BR3 readiness, customers are moving towards the most recent release of Oracle Argus Safety. pharmasol is pleased

to announce the addition of more customers to its client base running Argus Standard Edition 8.1.

Oracle Argus offers the following benefits;

*Make faster, better safety decisions with scientific querying and analytics

*Improve quality and efficiency through safety integration and automation

*Enhance compliance with E2B exchange and periodic reporting

*Conduct global case processing that scales easily to millions of cases

Using pharmasol's proprietary accelerated implementation approach, rapidLIVE, together with secure ISO-certified hosting from our EU data centres, pharmasol offers the most straightforward and cost effective deployment for this leading global safety database from Oracle.

rapidLIVE provides a pre-configured, ready to use workflow, with dedicated customer environments, thus enabling faster deployment into productive use and reducing overall implementation time to just two to three months.

About pharmasol

pharmasol is a leading provider of innovative applications, GxP compliant hosting and implementation services to the life sciences industry. With tools to automate complex business processes and the option to host applications in a secure managed data centre, pharmasol is trusted by leading pharmaceutical, medical device and contract research companies to optimize workflows and ensure compliance.

http://www.pharmasol.de

For further information, please contact: Tim Billington +44-7768-336-302 tim.billington@pharmasol.de

SOURCE pharmasol



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook